Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
31665 | 120 | 37.5 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GANKYRIN | Author keyword | 15 | 59% | 14% | 17 |
2 | P28GANK | Author keyword | 8 | 70% | 6% | 7 |
3 | PSMD10 | Author keyword | 6 | 100% | 3% | 4 |
4 | INTRACELLULAR PROTEOLYSIS | Address | 4 | 67% | 3% | 4 |
5 | TRIP BR | Author keyword | 3 | 100% | 3% | 3 |
6 | BIOMED SCI INTRACELLULAR PROTEOLYSIS | Address | 2 | 50% | 3% | 3 |
7 | CUEDC2 | Author keyword | 2 | 43% | 3% | 3 |
8 | PHD ZINC FINGER | Author keyword | 1 | 100% | 2% | 2 |
9 | TRIP BR1 | Author keyword | 1 | 100% | 2% | 2 |
10 | HSCO | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GANKYRIN | 15 | 59% | 14% | 17 | Search GANKYRIN | Search GANKYRIN |
2 | P28GANK | 8 | 70% | 6% | 7 | Search P28GANK | Search P28GANK |
3 | PSMD10 | 6 | 100% | 3% | 4 | Search PSMD10 | Search PSMD10 |
4 | TRIP BR | 3 | 100% | 3% | 3 | Search TRIP+BR | Search TRIP+BR |
5 | CUEDC2 | 2 | 43% | 3% | 3 | Search CUEDC2 | Search CUEDC2 |
6 | PHD ZINC FINGER | 1 | 100% | 2% | 2 | Search PHD+ZINC+FINGER | Search PHD+ZINC+FINGER |
7 | TRIP BR1 | 1 | 100% | 2% | 2 | Search TRIP+BR1 | Search TRIP+BR1 |
8 | HSCO | 1 | 50% | 1% | 1 | Search HSCO | Search HSCO |
9 | MIR 605 | 1 | 50% | 1% | 1 | Search MIR+605 | Search MIR+605 |
10 | NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA | 1 | 50% | 1% | 1 | Search NATIONAL+NATURAL+SCIENCE+FOUNDATION+OF+CHINA | Search NATIONAL+NATURAL+SCIENCE+FOUNDATION+OF+CHINA |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | P34SEI 1 | 8 | 75% | 5% | 6 |
2 | ONCOPROTEIN P28GANK | 6 | 80% | 3% | 4 |
3 | PROTEIN P34SEI 1 | 6 | 80% | 3% | 4 |
4 | TRIP BR | 6 | 71% | 4% | 5 |
5 | GANKYRIN | 6 | 39% | 10% | 12 |
6 | BR FAMILY | 6 | 100% | 3% | 4 |
7 | ONCOPROTEIN GANKYRIN | 2 | 38% | 4% | 5 |
8 | TRIP BR FAMILY | 2 | 67% | 2% | 2 |
9 | GANKYRIN PROMOTES | 1 | 100% | 2% | 2 |
10 | SEI 1 | 1 | 100% | 2% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Gankyrin: a new oncoprotein and regulator of pRb and p53 | 2006 | 38 | 45 | 24% |
Multiple interactive factors in hepatocarcinogenesis | 2014 | 18 | 86 | 6% |
Hepatocellular carcinoma and the ubiquitin-proteasome system | 2008 | 11 | 140 | 9% |
The development of targeted therapies for hepatocellular cancer | 2007 | 7 | 78 | 4% |
CUEDC2: an emerging key player in inflammation and tumorigenesis | 2011 | 7 | 38 | 3% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTRACELLULAR PROTEOLYSIS | 4 | 67% | 3.3% | 4 |
2 | BIOMED SCI INTRACELLULAR PROTEOLYSIS | 2 | 50% | 2.5% | 3 |
3 | PHARMACOL PATHOLCANC | 1 | 50% | 0.8% | 1 |
4 | SURGSAMSUNG BIOMED | 1 | 50% | 0.8% | 1 |
5 | BIOL SYSTGENE ENGN | 0 | 33% | 0.8% | 1 |
6 | EASTERN HEPATOBILIATY SURG HOSP | 0 | 33% | 0.8% | 1 |
7 | PREMED PRECIS MED | 0 | 33% | 0.8% | 1 |
8 | STEM CELL CONSORTIUM | 0 | 33% | 0.8% | 1 |
9 | HEPATOSPLEN SURGMINIST EDUC | 0 | 17% | 1.7% | 2 |
10 | KUNSHAN HOSP TRADIT CHINESE MED | 0 | 20% | 0.8% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000098308 | AFFIBODY MOLECULE//AFFIBODY MOLECULES//AFFIBODY |
2 | 0.0000093263 | P14ARF//P16//P16INK4A |
3 | 0.0000089924 | PROTEASOME//MULTICATALYTIC PROTEINASE//PA28 |
4 | 0.0000074076 | CHD1L//CODON 249//SUPPRESSION OF TUMORIGENICITY |
5 | 0.0000071850 | TIP30//EASTERN HOSP HEPATOBILIARY SURG//CC3 |
6 | 0.0000068880 | E2F//P107//P130 |
7 | 0.0000045742 | MOUSE HEPATOCARCINOGENESIS//METABOLIC ZONATION//EXPT PATHOL EP |
8 | 0.0000044972 | MIR 122//MICRORNA 122//MIR 224 |
9 | 0.0000044426 | MDM2//MDMX//NUTLIN 3 |
10 | 0.0000041546 | CCNG2//CYCLIN G2//CYCLIN G |